Agios Pharmaceuticals Inc. buy melinda
Start price
30.08.18
/
50%
€72.13
Target price
23.01.19
€90.20
Performance (%)
-36.26%
End price
23.01.19
€45.97
Summary
This prediction ended on 23.01.19 with a price of €45.97. The BUY prediction by melinda for Agios Pharmaceuticals Inc. performed very badly with a performance of -36.26%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Agios Pharmaceuticals Inc. | 7.746% | 7.746% | 50.000% | -33.261% |
| iShares Core DAX® | 0.961% | -2.210% | 12.839% | 17.154% |
| iShares Nasdaq 100 | 2.626% | -1.918% | 38.498% | 45.463% |
| iShares Nikkei 225® | 0.217% | -7.216% | 19.425% | 5.076% |
| iShares S&P 500 | 1.540% | -1.858% | 27.801% | 42.583% |
According to melinda what are the pros and cons of Agios Pharmaceuticals Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Agios Pharmaceuticals Inc. diskutieren
SecteurRecherche biotechnologique et médicale Agenda 08/11 Publication de résultats
Discovers and develops therapeutics
Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery and development of novel investigational medicines to treat cancer and rare genetic diseases.
It focuses on diseases that are directly caused by changes in genes or chromosomes, often passed from one generation to the next.
Its product candidates include IDHIFA, ivosidenib, AG-881, AG-348, and AG-270.
The comany was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.
Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery and development of novel investigational medicines to treat cancer and rare genetic diseases.
It focuses on diseases that are directly caused by changes in genes or chromosomes, often passed from one generation to the next.
Its product candidates include IDHIFA, ivosidenib, AG-881, AG-348, and AG-270.
The comany was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.
Nombre d'employés : 382 personnes.
(Vom Mitglied beendet)
Stopped prediction by melinda for Agios Pharmaceuticals Inc.
Agios Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€25.74
20.02.22
20.02.22
€30.00
20.03.22
20.03.22
2.76%
21.03.22
21.03.22
Could be worthwhile Investment >10% per year
Agios Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€35.02
21.12.20
21.12.20
€45.00
21.12.21
21.12.21
-13.14%
22.12.21
22.12.21
Could be worthwhile Investment >10% per year
Agios Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€56.06
24.03.19
24.03.19
€76.67
04.11.21
04.11.21
-37.53%
21.12.20
21.12.20
Could be worthwhile Investment >10% per year
Agios Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€59.21
14.09.17
14.09.17
€108.24
26.12.17
26.12.17
-11.80%
26.12.17
26.12.17
Could be worthwhile Investment >10% per year
Agios Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€65.65
14.09.17
14.09.17
€120.00
26.12.17
26.12.17
-11.80%
26.12.17
26.12.17
Could be worthwhile Investment >10% per year
Agios Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€52.41
29.08.17
29.08.17
€55.92
30.08.17
30.08.17
7.31%
30.08.17
30.08.17
Could be worthwhile Investment >10% per year
Agios Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€58.10
29.08.17
29.08.17
€62.00
30.08.17
30.08.17
7.31%
30.08.17
30.08.17
Could be worthwhile Investment >10% per year
Agios Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€43.49
30.05.17
30.05.17
€47.81
20.06.17
20.06.17
10.56%
20.06.17
20.06.17
Could be worthwhile Investment >10% per year
Agios Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€48.22
30.05.17
30.05.17
€53.00
20.06.17
20.06.17
10.56%
20.06.17
20.06.17
Could be worthwhile Investment >10% per year
Agios Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€44.13
25.04.17
25.04.17
€48.71
10.05.17
10.05.17
3.00%
10.05.17
10.05.17
Could be worthwhile Investment >10% per year
Agios Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€42.46
09.05.16
09.05.16
€48.71
31.05.16
31.05.16
16.74%
31.05.16
31.05.16
Could be worthwhile Investment >10% per year